Ferro Kevin
Insider CIK 1299331 · GHL Director · MLNT Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GHL GREENHILL & CO INC | D To issuer | 2023-11-30 | 2023-12-01 | 27,242 | — | $0 | 0 | SEC↗ |
| GHL GREENHILL & CO INC | D To issuer | 2023-11-30 | 2023-12-01 | 54,253 | — | $0 | 0 | SEC↗ |
| GHL GREENHILL & CO INC | A Award | 2023-04-03 | 2023-04-05 | 3,523 | — | $0 | 27,242 | SEC↗ |
| GHL GREENHILL & CO INC | A Award | 2023-01-04 | 2023-01-05 | 3,049 | — | $0 | 23,719 | SEC↗ |
| GHL GREENHILL & CO INC | A Award | 2022-10-04 | 2022-10-06 | 5,261 | — | $0 | 20,670 | SEC↗ |
| GHL GREENHILL & CO INC | A Award | 2022-07-05 | 2022-07-07 | 3,389 | — | $0 | 15,409 | SEC↗ |
| GHL GREENHILL & CO INC | P Buy | 2022-05-02 | 2022-05-04 | 10,000 | $12.15 | $121.5K | 12,020 | SEC↗ |
| GHL GREENHILL & CO INC | A Award | 2022-04-05 | 2022-04-06 | 2,020 | — | $0 | 56,273 | SEC↗ |
| GHL GREENHILL & CO INC | A Award | 2022-01-04 | 2022-01-05 | 1,743 | — | $0 | 54,253 | SEC↗ |
| GHL GREENHILL & CO INC | A Award | 2021-10-05 | 2021-10-07 | 2,137 | — | $0 | 52,510 | SEC↗ |
| GHL GREENHILL & CO INC | A Award | 2021-07-02 | 2021-07-06 | 2,008 | — | $0 | 50,373 | SEC↗ |
| GHL GREENHILL & CO INC | P Buy | 2021-05-11 | 2021-05-11 | 20,312 | $15.90 | $323.0K | 48,365 | SEC↗ |
| GHL GREENHILL & CO INC | P Buy | 2021-05-11 | 2021-05-11 | 15,625 | $15.91 | $248.6K | 28,053 | SEC↗ |
| GHL GREENHILL & CO INC | P Buy | 2021-05-07 | 2021-05-11 | 6,420 | $15.90 | $102.1K | 12,428 | SEC↗ |
| GHL GREENHILL & CO INC | A Award | 2021-04-06 | 2021-04-06 | 1,264 | — | $0 | 6,008 | SEC↗ |
| GHL GREENHILL & CO INC | P Buy | 2021-03-09 | 2021-03-09 | 4,244 | $14.50 | $61.5K | 4,744 | SEC↗ |
| GHL GREENHILL & CO INC | P Buy | 2021-03-05 | 2021-03-09 | 500 | $14.85 | $7.4K | 500 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2019-06-11 | 2019-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | P Buy deriv | 2019-02-22 | 2019-02-26 | 9,375,000 | $8.00 | $75.00M | 9,375,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2018-06-12 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2018-06-12 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | P Buy | 2018-05-29 | 2018-05-31 | 7,878,500 | $5.00 | $39.39M | 16,607,959 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | P Buy | 2018-05-29 | 2018-05-31 | 7,500,000 | $5.00 | $37.50M | 16,007,237 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | P Buy | 2018-05-29 | 2018-05-31 | 7,878,500 | $5.00 | $39.39M | 16,607,959 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | P Buy | 2018-01-05 | 2018-01-09 | 1,777,778 | $13.50 | $24.00M | 8,507,237 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | P Buy | 2018-01-05 | 2018-01-09 | 2,000,000 | $13.50 | $27.00M | 8,729,459 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | P Buy | 2018-01-05 | 2018-01-09 | 2,000,000 | $13.50 | $27.00M | 8,729,459 | SEC↗ |